These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

641 related articles for article (PubMed ID: 9152030)

  • 1. Moraxella (Branhamella) catarrhalis--clinical and molecular aspects of a rediscovered pathogen.
    Enright MC; McKenzie H
    J Med Microbiol; 1997 May; 46(5):360-71. PubMed ID: 9152030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.
    McGregor K; Chang BJ; Mee BJ; Riley TV
    Eur J Clin Microbiol Infect Dis; 1998 Apr; 17(4):219-34. PubMed ID: 9707304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic-sensitivity of Moraxella catarrhalis isolated from clinical materials in 1997-1998.
    Mikucka A; Janicka G; Krawiecka D; Kochanowska J
    Med Sci Monit; 2000; 6(2):300-4. PubMed ID: 11208326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical, diagnostic and therapeutic aspects of Moraxella catarrhalis infections].
    Bourgeois F; Lambert-Zechovsky N; Bingen E
    Pathol Biol (Paris); 1993 Jun; 41(6):555-61. PubMed ID: 8247636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moraxella catarrhalis: a review of an important human mucosal pathogen.
    Karalus R; Campagnari A
    Microbes Infect; 2000 Apr; 2(5):547-59. PubMed ID: 10865200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial resistance of Moraxella catarrhalis isolates in Taiwan.
    Hsu SF; Lin YT; Chen TL; Siu LK; Hsueh PR; Huang ST; Fung CP
    J Microbiol Immunol Infect; 2012 Apr; 45(2):134-40. PubMed ID: 22154675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of Moraxella catarrhalis in patients at King Khalid University Hospital, Riyadh.
    Babay HA
    Saudi Med J; 2000 Sep; 21(9):860-3. PubMed ID: 11376364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular characterization of BRO beta-lactamases of Moraxella catarrhalis strains isolated from carrier children].
    Köseoğlu O; Ergin A; Gürkan Aydin N; Hasçelik G
    Mikrobiyol Bul; 2004 Oct; 38(4):335-40. PubMed ID: 15700658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Infections caused by Branhamella catarrhalis].
    Ejlertsen T; Schønheyder H
    Ugeskr Laeger; 1990 Feb; 152(7):475-7. PubMed ID: 2106743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of antimicrobial therapy on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, and Branhamella catarrhalis in children with respiratory tract infections.
    Varon E; Levy C; De La Rocque F; Boucherat M; Deforche D; Podglajen I; Navel M; Cohen R
    Clin Infect Dis; 2000 Aug; 31(2):477-81. PubMed ID: 10987708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Moraxella catarrhalis by DNA typing: evidence for a distinct subpopulation associated with virulence traits.
    Bootsma HJ; van der Heide HG; van de Pas S; Schouls LM; Mooi FR
    J Infect Dis; 2000 Apr; 181(4):1376-87. PubMed ID: 10762569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Branhamella catarrhalis as a disease pathogen].
    Simon C
    Fortschr Med; 1991 Jul; 109(22):447-8. PubMed ID: 1937324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of genes encoding virulence factors ompB2, ompCD, ompE, β-lactamase and serotype in pathogenic and colonizing strains of Moraxella catarrhalis.
    Mitov IG; Gergova RT; Ouzounova-Raykova VV
    Arch Med Res; 2010 Oct; 41(7):530-5. PubMed ID: 21167392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Branhamella (Moraxella) catarrhalis--a clinically relevant pathogen of bronchopulmonary diseases?].
    Radzuweit S; Kalich R
    Z Erkr Atmungsorgane; 1991; 177(1-2):82-7. PubMed ID: 1808857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moraxella catarrhalis, a human respiratory tract pathogen.
    Murphy TF; Parameswaran GI
    Clin Infect Dis; 2009 Jul; 49(1):124-31. PubMed ID: 19480579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Branhamella catarrhalis in respiratory infections].
    Marín Casanova P; García-Martos P; Fernández Fatou B; Bernal García F; Agudo Pérez E
    Rev Clin Esp; 1989 May; 184(8):399-400. PubMed ID: 2506614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moraxella catarrhalis in upper respiratory tract of healthy Yemeni children/adults and paediatric patients: detection and significance.
    Sehgal SC; al Shaimy I
    Infection; 1994; 22(3):193-6. PubMed ID: 7927815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents.
    Jacobs MR; Felmingham D; Appelbaum PC; Grüneberg RN;
    J Antimicrob Chemother; 2003 Aug; 52(2):229-46. PubMed ID: 12865398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Moraxella catarrhalis: virulence and resistance mechanisms].
    Cullmann W
    Med Klin (Munich); 1997 Mar; 92(3):162-6. PubMed ID: 9173208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Moraxella (Branhamella) catarrhalis. A common pathogenic agent].
    Prost J; Scavizzi M
    Presse Med; 1993 May 1-8; 22(16):779-82. PubMed ID: 8316533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.